Navigation Links
Arpida Announces Agenda Items for Shareholders Meeting
Date:4/15/2008

REINACH, Switzerland, April 15 /PRNewswire-FirstCall/ -- Arpida Ltd. (SWX: ARPN) today published the agenda for the Annual General Meeting of Shareholders, to be held in Basel on 7 May 2008. The invitation appears today in several Swiss media and will be sent to all registered Arpida shareholders. The agenda is available on the website http://www.arpida.com.

Apart from the yearly recurring agenda items, Arpida's Board of Directors will put two additional proposals to the shareholders.

The first additional agenda item relates to the proposed appointment of Elmar Schnee to the Board of Directors.

Elmar Schnee is a highly experienced Pharma executive who has gathered a wealth of international experience at several large and small pharmaceutical companies. He is currently President of Merck Serono S.A. and Regular Member of the Executive Board and General Partner of Merck KGaA, with responsibility for the Pharmaceuticals business sector. Mr Schnee is a Swiss national.

The terms of three current Arpida Board members expire in the AGM of 7 May 2008 and all three will stand for re-election. Professor Nam-Hai Chua, a Board member since 2004, has resigned from the Board.

The second additional proposal is aimed at increasing Arpida's flexibility in terms of potential financing instruments. In the past, Arpida's funds have primarily been provided by equity investors through the issue of shares. Going forward, Arpida may consider alternative sources of funding such as, for instance, convertible bonds.

In order to create the possibility to issue such instruments, the Company will ask its shareholders to make the necessary changes to its Articles of Association. If the shareholders' meeting approves these changes, Arpida will have the possibility to issue a total of no more than 3.2 million shares (15% of the currently outstanding share capital), either via a straight equity issue (
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections
2. Arpida Announces Full Year 2007 Financial Results
3. Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim
4. Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis
5. Arpida Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim
6. Arpida-Supported CME Symposium Available Online
7. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
8. Arpida Presents Preclinical Data on AR-2474 at ICAAC
9. Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
10. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
11. Arpida Interim Results for six Months to 30 June 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) today announced ... Officer has resigned.  The Company has hired Andrew ... in December 2014, as full time interim CFO and ... Andy Ashworth began his employment today, ... transition.  Andy was the Company,s CFO from September 2011 ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... announces the launch of their 2nd generation cell therapy POD® design. The 2nd ... but it also represents a new POD® design. , “G-CON first offered ...
(Date:7/29/2015)... 29, 2015  AmnioChor Inc., an early stage biotech ... pleased to announce that the Musculoskeletal Transplant Foundation of ... invest in their seed round of development of the ... capabilities. AmnioChor,s technology allows cryopreservation of ... stem cells living within those tissues. Amnion is a ...
(Date:7/29/2015)...  Indivior PLC (LON: INDV) today announced that the ... accepted and received Priority Review by the U.S. Food ... overdose. This naloxone nasal spray comes as a pre-filled ... into the nasal mucosa. 1 The device has ... be better equipped to help an opioid overdose victim. ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5
... 2 Sicel Technologies, Inc., announced today that ... bankruptcy. Effective August 31, 2010, Paul McDaniel became ... the company. Currently, Sicel,s operations are continuing and ... returned to work.Media Contact: Lisa P. Sumner, Esq., ...
... Cell Treatments -- SHENZHEN, China, Sept. 2 /PRNewswire-Asia/ -- ... ... ... // Results are keyed by longUrl, so we need to grab the first one. for (var r ...
... growing interest in using nanoparticles for everything from ... the need to understand the environmental, health and ... at the National Institute of Standards and Technology ... nanocrystals that will enable studies of certain physical ...
Cached Biology Technology:New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 2New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 3New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 4New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 5New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 6New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 7New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 8The perfect nanocube: Precise control of size, shape and composition 2
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
(Date:7/7/2015)... , July 7, 2015  Based on its ... & Sullivan recognizes Credence ID, LLC with the ... Company of the Year Award. Credence ID has ... in its mission of offering enrollment and identification ... As Credence ID was formed by experts from ...
(Date:6/30/2015)... , June 30, 2015 To bolster its efforts ... HYPR Corp. announced today the addition of two new team ... as board advisor and David Raviv will act ... underscore HYPR Corp.,s commitment to providing the most secure solutions ... Sirota co-founded Layer 7 Technologies, a provider of security ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... typically associated with trees; they can take centuries to grow. However, ... in the Proceedings of the National Academy of Sciences ... growing faster than they have in the past 225 years. The ... to ,climate change. For more than 20 years forest ecologist ...
... day care workers and kindergarten teachers tend to offer young humans ... sharing just comes naturally. In fact, according to a pair ... like bonobos never seem to learn how not to share. ... by physical aggression if necessary. While chimps will share as youngsters, ...
... one day walk on walls, like Spider-Man? A palm-sized device ... adhesive bond just might make it possible. The rapid ... gloves that stick and unstick to walls, or Post-it-like notes ... chemical and biomolecular engineering, who invented the device with Michael ...
Cached Biology News:Ecologists discover forests are growing faster 2Ecologists discover forests are growing faster 3'Peter Pan' apes never seem to learn selfishness 2'Peter Pan' apes never seem to learn selfishness 3New adhesive device could let humans walk on walls 2
KNP-1 (HES1) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 35, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details....
Request Info...
Form: Ready to use Applications: Immunohistology-frozen, Immunohistology-paraffin, Western Blot, ELISA...
... Specifications(L x W x H): 17 ... 5 5/16"18.7 lbsCapacity: 12 slidesTime: Programmable 0 ... Automated denaturation and hybridization steps 40 user ... only, and Fixed temperature) Rapid temperature ramp-up ...
Biology Products: